Literature DB >> 11390720

Angiographic progression of coronary artery disease in patients with end-stage renal disease.

F Gradaus1, K Ivens, A J Peters, P Heering, F C Schoebel, B Grabensee, B E Strauer.   

Abstract

BACKGROUND: Patients with end-stage renal disease have an increased risk of developing coronary artery disease (CAD). The cardiovascular mortality of dialysis patients is 10-15 times higher compared with the general population. The aim of our study was to evaluate the morphological progression of coronary arteriosclerosis in this cardiovascular high-risk group by visual assessment and quantitative coronary angiography. Methods and results. In 26 patients with chronic renal failure (age, 47+/-11 years; 15 male; duration of dialysis, 23+/-25 months) the severity of CAD and degree of coronary stenoses were assessed in two coronary angiograms after a mean follow-up interval of 30+/-15 months (12-60). Baseline angiography revealed CAD in 13/22 patients (59%). The second angiography was performed as screening procedure prior to renal transplantation (n=20) and/or as follow-up angiography after coronary angioplasty (n=10). Visual assessment showed a progression defined by the development of haemodynamically relevant stenosis of >50% luminal diameter in 13 patients. Quantitative angiographic evaluation was performed in a total of 45 segments showing >25% narrowing at the second angiogram. A progression (>15% luminal reduction) was found in 17 of 45 segments, a new lesion (initial luminal diameter <20%) was detected in nine segments, resulting in progression or new lesion in 16 patients (62%). Patients with or without progression did not differ in age, duration of dialysis treatment, number of cardiovascular risk factors, or serum total cholesterol and fibrinogen levels. After percutaneous transluminal coronary angioplasty (PTCA) a restenosis was seen in seven of 16 primarily successfully dilated segments. After the second angiography, myocardial revascularization was performed in eight patients (1 PTCA, 7 coronary artery bypass graft).
CONCLUSIONS: Patients with end-stage renal disease have a high prevalence of CAD. In line with the clinical course, CAD patients on maintenance dialysis undergo rapid angiographic progression of CAD, which results in a high rate of subsequent myocardial revascularizations.

Entities:  

Mesh:

Year:  2001        PMID: 11390720     DOI: 10.1093/ndt/16.6.1198

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.

Authors:  Sahar A Fathallah-Shaykh; Ellen R Brooks; Craig B Langman; Kenneth R Kensey
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

2.  [Heart and kidneys].

Authors:  D Kiski; H Reinecke
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

3.  Cardiometabolic risk profile of rural South Indians undergoing coronary interventions.

Authors:  Manne Sriharibabu; Yalamanchali Himabindu; Zubair Kabir
Journal:  Heart Asia       Date:  2012-10-24

4.  Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Sharmila Dorbala; David M Charytan; Ron Blankstein; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2012-10

5.  Cardiac evaluation prior to kidney transplantation.

Authors:  Rowena B Delos Santos; Aleksandra Gmurczyk; Jagdeep S Obhrai; Suzanne G Watnick
Journal:  Semin Dial       Date:  2010 May-Jun       Impact factor: 3.455

6.  Factors associated with early mortality in haemodialysis patients undergoing coronary artery bypass surgery.

Authors:  Deniz Çevirme; Taylan Adademir; Mehmet Aksüt; Tülay Örki; Kamil Cantürk Çakalağaoğlu; Mete Alp; Kaan Kirali
Journal:  Cardiovasc J Afr       Date:  2016-07-22       Impact factor: 1.167

7.  Circulating miRNAs and Vascular Injury Markers Associate with Cardiovascular Function in Older Patients Reaching End-Stage Kidney Disease.

Authors:  Qiao Zhao; Sabine J L Nooren; Laurien E Zijlstra; Jos J M Westenberg; Lucia J M Kroft; J Wouter Jukema; Noeleen C Berkhout-Byrne; Ton J Rabelink; Anton Jan van Zonneveld; Marjolijn van Buren; Simon P Mooijaart; Roel Bijkerk
Journal:  Noncoding RNA       Date:  2022-01-10

8.  The risk of atherosclerosis in patients with chronic kidney disease.

Authors:  Sylwia Olechnowicz-Tietz; Anna Gluba; Anna Paradowska; Maciej Banach; Jacek Rysz
Journal:  Int Urol Nephrol       Date:  2013-03-13       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.